Rigidtransient Universally Internalizing RNA: A Promising Drug Target for Viral Infections

Target Name: RDUR

NCBI ID: G152225

RDUR

Other Name(s): RIG-I dependent antiviral response regulator RNA | LINC02085

Rigidtransient Universally Internalizing RNA: A Promising Drug Target for Viral Infections

Rigidtransient universally internalizing RNA (RDUR) is a non-coding RNA molecule that plays a crucial role in the antiviral response of RNA-dependent RNA polymerase (RIG-I) to various viral infections. RIG-I is a key enzyme in the translation of RNA templates, and it is involved in the production of a wide range of RNA molecules, including viruses, plasmids, and smallRNAs. RIG-I-mediated antiviral response is a critical element of the host's immune system, and it is highly conserved across different organisms.

The antiviral response is a complex process that involves multiple steps, including the detection of incoming viral particles, the engagement of viral immune responses, and the elimination of infected cells. One of the key factors that regulate this response is RDUR, a RNA molecule that is highly conserved across different organisms and is involved in the antiviral response of RIG-I.

Drug Target or Biomarker

RDUR is a drug target or biomarker that may be targeted by small molecule inhibitors to enhance the antiviral response of RIG-I. The use of small molecules as inhibitors of RDUR is an attractive approach for the development of new antiviral drugs, as it allows for the targeting of a specific RNA molecule that is involved in the host's immune response.

The mechanism of action of RDUR is well understood, and it is a key regulator of the antiviral response of RIG-I. RDUR functions as a negative regulator of RIG-I, and it binds to the active site of RIG-I, preventing the substrate from binding and activating the enzyme. This inhibition of RIG-I activity renders the host's immune system less effective in fighting off viral infections, making it an attractive target for small molecule inhibitors.

RDUR is a conserved RNA molecule that is highly conserved across different organisms, including bacteria, archaea, and eukaryotes. It is found in various cellular organelles, including the cytoplasm, the endoplasmic reticulum, and the nuclear pleuroplasm.

Expression and regulation

RDUR is highly expressed in various organisms, including bacteria, archaea, and eukaryotes. It is a key component of the host's immune system, and it plays a crucial role in the antiviral response of RIG-I.

RDUR is regulated at both the transcription and translation levels. During the transcription process, RDUR binds to the promoter region of RIG-I and binds to other proteins to prevent RNA polymerase from binding and initiating gene transcription. During the translation process, RDUR binds to the nucleotide of RIG-I, preventing nucleotide binding and initiating translation of the polypeptide chain.

The synthesis and degradation of RDUR are accomplished through multiple pathways. In bacteria, the synthesis and degradation of RDUR is completed by RIG-I itself. RIG-I recruits ADP nucleotides to its active center by phosphorylating the conserved groups of RDUR and uses these nucleotides to synthesize new RDUR molecules. In terms of degradation, RDUR is hydrolyzed into small molecule RNA or DNA by specific degradation enzymes.

pharmacological significance

RDUR is a molecule of pharmacological significance because it is a novel target that can be used to treat many viral infections, including colds, influenza, HIV, and HCV. Since RDUR is a conserved molecule, a variety of RDUR inhibitors can be developed, which can inhibit the activity of RDUR, thereby enhancing the antiviral ability of the host immune system.

Currently, a variety of RDUR inhibitors have been developed and used in clinical trials. These inhibitors include RNA interference molecules, small RNA binding proteins, and nucleotide binding inhibitors. These inhibitors can significantly improve the antiviral ability of host cells and thus have good prospects for treating viral infections.

Conclusion

RDUR is an important molecule in

Protein Name: RIG-I Dependent Antiviral Response Regulator RNA

The "RDUR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RDUR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets